Where Global Innovation
and Capital Meet

ONL lines up series B funding

Dec 29, 2020 • Callum Cyrus

U-M's retinal disease drug developer has secured $46.9m of series B capital from investors including Mints.

ONL Therapeutics, a US-based retinal diseases therapy developer spun out of University of Michigan, has closed a $46.9m series B round featuring the institution’s Michigan Investment in New Technology Startups (Mints) programme. Western Michigan University’s Biosciences Research & Commercialization Center also took part in the round. The round was led by venture capital firm Bios…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

Resistance is futile: seven superconductor companies that want to change the world

From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.

UK universities urged to lower spinout stakes

A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.

Founders: here’s how to get your product into the NHS

Startups often find the UK's National Health Service hard to sell into. These three tips can stop founders falling at the first hurdle.

Events

Webinar: Reaching for the sun - Is it time to invest in fusion?

Dec 13, 2023
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Feb 6 -
Feb 7, 2024
Online

Find out more All events

Events

GCVI Summit 2024

Mar 12 -
Mar 14, 2024
Monterey, CA (USA)

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.